| Literature DB >> 21835709 |
Susanne Holzhauer1, Barbara Zieger.
Abstract
Thrombocytopenia is the most common haematological abnormality in newborns admitted to neonatal care units and serves as an important indicator of underlying pathological processes of mother or child. In most cases thrombocytopenia is mild to moderate and resolves within the first weeks of life without any intervention. However, in some neonates thrombocytopenia is severe or may reflect an inborn platelet disorder. As clinical course and outcome of thrombocytopenia depend on the aetiology of thrombocytopenia, an appropriate work-up is essential to guide therapy in neonates with thrombocytopenia and to avoid severe bleeding.Entities:
Mesh:
Year: 2011 PMID: 21835709 DOI: 10.1016/j.siny.2011.07.008
Source DB: PubMed Journal: Semin Fetal Neonatal Med ISSN: 1744-165X Impact factor: 3.926